Al W. Kraus's most recent trade in Cytosorbents Corp was a trade of 12,000 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on Feb. 6, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytosorbents Corp | Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 06 Feb 2023 | 12,000 | 142,046 (0%) | 0% | 2.7 | 31,800 | Common Stock |
| Cytosorbents Corp | Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 12,000 | 0 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Al W. Kraus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 37,950 | 37,950 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Al W. Kraus | Director | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 06 May 2022 | 5,000 | 130,046 (0%) | 0% | 2.0 | 9,795 | Common Stock |
| Cytosorbents Corp | Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 31 Aug 2021 | 4,000 | 129,046 (0%) | 0% | 4.1 | 16,500 | Common Stock |
| Cytosorbents Corp | Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2021 | 4,000 | 0 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Al W. Kraus | Director | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 31 Aug 2021 | 4,000 | 125,046 (0%) | 0% | 9.4 | 37,591 | Common Stock |
| Cytosorbents Corp | Al W. Kraus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 34,500 | 34,500 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Al W. Kraus | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 10 Nov 2020 | 8,000 | 125,046 (0%) | 0% | 8 | 64,000 | Common Stock |
| Cytosorbents Corp | Al W. Kraus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.45 per share. | 10 Nov 2020 | 8,000 | 133,046 (0%) | 0% | 3.5 | 27,600 | Common Stock |